Please check your internet connection and try again.
# Megacv Duo
*(Note: Commonly refers to a Co-amoxiclav formulation: Amoxicillin + Clavulanate Potassium)*
## Overview
Megacv Duo is a combination antibiotic consisting of amoxicillin (a beta-lactam) and clavulanic acid (a beta-lactamase inhibitor). The inhibitor expands the spectrum of activity to include beta-lactamase-producing strains.
## Primary Indications
Used for infections caused by susceptible organisms, including respiratory tract infections, otitis media, sinusitis, skin and soft tissue infections, and urinary tract infections. Specific indications include pneumonia, bites (animal/human), and dental infections.
## Adult Dosing
Standard dosing is based on the amoxicillin component:
* Mild to moderate infections: 500 mg amoxicillin every 8 or 12 hours.
* Severe infections: 875 mg amoxicillin every 12 hours or 500 mg every 8 hours.
* "Duo" formulations often utilize the 875/125 mg tablet strength administered every 12 hours.
## Pediatric Dosing
Dosing is weight-based (based on amoxicillin component):
* 20 mg/kg/day to 45 mg/kg/day in divided doses every 8 to 12 hours.
* Recurrent or persistent otitis media: Up to 90 mg/kg/day, typically utilizing a high-potency suspension to minimize clavulanate exposure.
* *Consult local antimicrobial stewardship guidelines as these vary significantly by region and resistance patterns.*
## Dose Adjustments
* Renal Impairment: Dose reduction required for CrCl < 30 mL/min. Avoid extended-release formulations in severe renal failure.
* Hepatic Impairment: Use with caution; monitor liver function.
## Contraindications
* History of amoxicillin-associated cholestatic jaundice or hepatic dysfunction.
* Known hypersensitivity to penicillins or any component of the formulation.
* Severe renal impairment (CrCl < 30 mL/min for specific high-dose formulations).
## Adverse Effects
* Common: Diarrhea, nausea, vomiting, abdominal pain, candidiasis (oral or vaginal).
* Serious: Anaphylaxis, Clostridioides difficile-associated diarrhea (CDAD), hepatotoxicity (transient elevation of LFTs, cholestatic jaundice), skin rash (Stevens-Johnson syndrome, DRESS).
## Key Drug Interactions
* Methotrexate: May decrease clearance, increasing toxicity risk.
* Warfarin: May increase INR (monitor closely when starting/stopping).
* Probenecid: Increases and prolongs serum amoxicillin levels.
* Oral Contraceptives: Potential for reduced efficacy (though evidence is debated; advise backup for high-risk patients).
## Monitoring
* Renal and hepatic function periodically during prolonged therapy.
* Monitor for signs of hypersensitivity or severe cutaneous adverse reactions.
* Monitor for signs of secondary infection or worsening diarrhea.
## Clinical Pearls
* Administer at the start of a meal to improve tolerability and minimize gastrointestinal distress.
* Clavulanate content varies by suspension/tablet strength; ensure the mg/kg ratios are verified to prevent diarrhea from excess clavulanate.
* Not effective against atypical bacteria (e.g., *Mycoplasma*, *Legionella*).
* Drug-induced rash (non-allergic) can occur frequently in patients with infectious mononucleosis.
***
**Educational Disclaimer:** This information is for educational purposes only. Always consult the institution’s current antimicrobial stewardship guidelines, local antibiograms, and the official FDA/EMA-approved prescribing information (package insert) before prescribing or administering medication. Dosage must be verified against patient-specific renal function and weight.
